Mantel-Teeuwisse, A.K.

patient anti-obesity anti-obesity drugs study statin subject genotype drug use 2009 john wiley co-morbiditie therapy å4 å4 genotype index date effect characteristic disease anti-obesity drug baseline discontinuation anti-obesity drug use cholesterol netherland prescription diabetes mellitus dosage diabetes cohort information use anti-obesity drugs population starter index obesity rimonabant orlistat apolipoprotein women statin therapy reference bene fits sibutramine duration allele mellitu drug safety copyright response diagnose number treatment amphetamine-like drugs å2 å3 genotype rotterdam rotterdam study fi rst prescription table bene fit balance baseline characteristics safety level signi ficant differences record pharmacoepidemiology fluramine pattern signi database å4 allele wiley amphetamine-like prevalence weight history trial result january ficant diagnosis polymorphism apolipoprotein e polymorphism